Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

First-ever county-level estimates of Alzheimer's prevalence released at AAIC 2023

The first-ever county-level estimates of the prevalence of people with Alzheimer's dementia — in all 3,142 United States counties — were released today at the Alzheimer's Association International Conference 2023, in Amsterdam, Netherlands, and online.

17 Jul 2023

Touching lives: understanding factors for successful touch interventions

Researchers aimed to understand the impact of touch interventions on mental and physical health.

17 Jul 2023

New proteomic insights: cerebrospinal fluid biomarkers show promise in detecting dementia with Lewy bodies

Researchers conducted cerebrospinal fluid (CSF) proteome profiling and identified CSF proteins.

17 Jul 2023

DFG funds new clinical research unit to study autoimmune-mediated neurological diseases

How do neurological disorders arise that are caused, triggered, or influenced by antibodies? What better possibilities are there for diagnosis – and above all for treatment? These are the questions addressed by the new Clinical Research Unit "BecauseY" headed by Charité – Universitätsmedizin Berlin. Innovative treatment options will especially benefit patients who at first glance are not suspected of having an antibody-mediated neurological disease.

14 Jul 2023

Quanterix launches LucentAD Biomarker blood test to aid physician diagnosis of Alzheimer’s disease in patients

Quanterix Corporation, a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced it has launched LucentAD, a test to assist in the evaluation of patients experiencing cognitive symptoms consistent with the early signs of Alzheimer’s disease (AD).

From Quanterix 14 Jul 2023

Study suggests anxiety increases the risk of subsequent cognitive progression in non-dementia elderly

Researchers investigate the effects of anxiety on cognitive degeneration in non-dementia elderly.

14 Jul 2023

Superagers more likely to have greater movement speed than typical older adults

People in their eighties who can recall everyday events and life experiences as well as someone 20 to 30 years younger – known as superagers – are also more likely to have greater movement speed than typical older adults.

13 Jul 2023

AI tool accurately counts brain lesions on MRI scans within seconds

An artificial intelligence (AI) tool developed at The University of Texas Health Science Center at San Antonio accurately counts brain lesions on MRI scans within seconds.

13 Jul 2023

MemTrax continuous recognition test shows promise in early detection of Alzheimer's disease

A new editorial paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 12, entitled, "Advancing screening for cognitive impairment: the memtrax continuous recognition test."

13 Jul 2023

New biomarker could track progression of Alzheimer's disease

Two pathologies drive the progression of Alzheimer's disease. Early on, amyloid beta plaques lead the way, but around the time cognitive symptoms arise, tau tangles take over as the driving force and cognition steadily declines.

13 Jul 2023

Monumental $11.5 million gift will enable FAU to find a cure for amyloidosis

Currently, there is no cure for amyloidosis, a life-threatening disease that can be present throughout the body, including the heart, kidneys, liver and brain. The most common localized form of amyloidosis, which is seen significantly more often, is in the brain.

13 Jul 2023

British neuroscientist wins Hartwig Piepenbrock-DZNE Prize for contributions to dementia research

This year's "Hartwig Piepenbrock-DZNE Prize", endowed with 60,000 euros, goes to the British neuroscientist Alison Goate, DPhil. The award recognizes her outstanding contributions to research into Alzheimer's disease and frontotemporal dementia.

13 Jul 2023

Overdosed gene on chromosome 21 accelerates aging in people with Down's syndrome

An overdosed gene on chromosome 21 causes people with Down's Syndrome to age faster than the general population.

12 Jul 2023

Social isolation linked to brain volume loss in older adults

Older people who have little social contact with others may be more likely to have loss of overall brain volume, and in areas of the brain affected by dementia, than people with more frequent social contact, according to a study published in the July 12, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

12 Jul 2023

New AI-aided biosensor developed to detect neurodegenerative diseases

By combining multiple advanced technologies into a single system, EPFL researchers have made a significant step forward in diagnosing neurodegenerative diseases (NDDs) such as Parkinson's disease (PD) and Alzheimer's disease (AD).

12 Jul 2023

AI-enhanced companion robots may help alleviate the loneliness epidemic in future

Companion robots enhanced with artificial intelligence may one day help alleviate the loneliness epidemic, suggests a new report from researchers at Auckland, Duke, and Cornell Universities.

12 Jul 2023

Lecanemab: First disease-modifying therapy for Alzheimer's disease approved by FDA

On July 6, 2023, the U.S. Food and Drug Administration granted full approval to lecanemab, marketed as Leqembi, for the treatment of Alzheimer's disease.

12 Jul 2023

Older age and certain health conditions increase risk of COVID-19 death in boosted individuals

Researchers identify patient groups at a higher risk of death due to COVID-19 among adults who received a second booster dose in England.

12 Jul 2023

£1.5 million funding boost awarded for revolutionary test to improve early detection of Alzheimer's

A significant NIHR grant will enable researchers at the universities of Bath and Bristol, in collaboration with Cumulus Neuroscience, to develop revolutionary technology to help expand early dementia diagnosis.

11 Jul 2023

$40.5 million NIA grant to fund study of Alzheimer's disease in Asian Americans and Asian Canadians

A $40.5 million grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), will fund the Asian Cohort for Alzheimer's Disease (ACAD) study at Penn Medicine and 15 other academic research centers across the United States and Canada.

11 Jul 2023

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

First-ever county-level estimates of Alzheimer's prevalence released at AAIC 2023

Touching lives: understanding factors for successful touch interventions

New proteomic insights: cerebrospinal fluid biomarkers show promise in detecting dementia with Lewy bodies

DFG funds new clinical research unit to study autoimmune-mediated neurological diseases

Quanterix launches LucentAD Biomarker blood test to aid physician diagnosis of Alzheimer’s disease in patients

Study suggests anxiety increases the risk of subsequent cognitive progression in non-dementia elderly

Superagers more likely to have greater movement speed than typical older adults

AI tool accurately counts brain lesions on MRI scans within seconds

MemTrax continuous recognition test shows promise in early detection of Alzheimer's disease

New biomarker could track progression of Alzheimer's disease

Monumental $11.5 million gift will enable FAU to find a cure for amyloidosis

British neuroscientist wins Hartwig Piepenbrock-DZNE Prize for contributions to dementia research

Overdosed gene on chromosome 21 accelerates aging in people with Down's syndrome

Social isolation linked to brain volume loss in older adults

New AI-aided biosensor developed to detect neurodegenerative diseases

AI-enhanced companion robots may help alleviate the loneliness epidemic in future

Lecanemab: First disease-modifying therapy for Alzheimer's disease approved by FDA

Older age and certain health conditions increase risk of COVID-19 death in boosted individuals

£1.5 million funding boost awarded for revolutionary test to improve early detection of Alzheimer's

$40.5 million NIA grant to fund study of Alzheimer's disease in Asian Americans and Asian Canadians

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in